Insights from Industry RSS Feed - Insights from Industry

"Insights from Industry" is a dynamic series of interviews at the cutting edge of the medical industry. Every interviewee is a leader in their particular field and is handpicked to give an informative and accessible insight into their chosen field. These interviews are guaranteed to keep you in the know in a rapidly changing industry.
Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Reducing hospital readmissions through Transitional Care: an interview with Rani Khetarpal

Services provided to a patient whose medical and/or psychosocial problems require moderate or high-complexity medical decision making during transitions in care from an inpatient setting, partial hospital, observation status in a hospital, or skilled nursing facility to the patient’s community setting. [More]
Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Applying a top restaurant model to healthcare communications: an interview with Brandi Robinson, Sanofi

Communications professionals often are expected to be experts in all facets of the vast spectrum of communications, from brand, corporate, crisis and digital communications to corporate reputation and channel strategy and everything in between. [More]
Voice cloning: an interview with Paul Welham, CEO, CereProc

Voice cloning: an interview with Paul Welham, CEO, CereProc

CereVoice Me was essentially designed for those who had been diagnosed with MND/ALS and other illnesses that may cause an individual to lose the power of speech. CereProc identified that there was a gap in the market and pulled our resources together to build CereVoice Me, the goal of the service is to build a TTS voice efficiently and at a cost effective price. [More]
Multiple sclerosis relapse management: an interview with Gina Remington

Multiple sclerosis relapse management: an interview with Gina Remington

MS relapses are typically reflective of new neurological symptoms. However, it can be a worsening of neurologic symptoms that begins after a patient has been stable (generally for about 30 days), but relapses are persistent and consistent changes in symptoms that occur for more than 24 to 48 hours. [More]
Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

Innovation in anaesthesia: an interview with Matti Lehtonen, GE Healthcare

The spectrum of patients seen today, from pre-term infants to the morbidly obese to the longer living elderly, is wider than ever before and increasingly more challenging with patients often presenting with multiple co-morbidities. This puts a huge strain on healthcare providers who are facing increasing challenges such as cost pressure and staff shortages. [More]
Artemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi

Artemisinin and the fight against malaria: an interview with Dr. Robert Sebbag, Sanofi

Since 2014, more than 16 million anti-malarial treatments derived from the Sanofi patented process for semi-synthetic artemisinin have been supplied to endemic countries in Africa. [More]
NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

NHS access - are you ready? An interview with Dr Keith Morris, Morris Healthcare Consulting

The NHS is under immense pressure not only to continue to deliver improved care but also to change how it is delivering care to meet rising and changing demand with an essentially fixed amount of money and resources - all at the same time. Patience and persistence with good humour are thus vital characteristics to have. [More]
Scientific CMOS advantages over CCD: an interview with Robert LaBelle

Scientific CMOS advantages over CCD: an interview with Robert LaBelle

The optiMOS sCMOS camera from QImaging is a new alternative to CCD based cameras for fluorescence microscopy, particularly when capturing fast cellular events. This frame-rate improvement was achieved while substantially increasing the camera’s field-of-view and the ability to measure low light signals. [More]
Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

Identifying obstructive coronary artery disease in women: an interview with Dr. Ladapo, NYU School of Medicine

A recent study presented at the American College of Cardiology 64th Annual Scientific Meeting evaluated the impact of an age, sex, and gene expression score on clinical decision-making and the rate of further cardiac evaluation in symptomatic female patients suggestive of CAD in the outpatient setting. [More]
Supporting life science innovation: an interview with Ger Brophy, CTO, GE Healthcare Life Sciences

Supporting life science innovation: an interview with Ger Brophy, CTO, GE Healthcare Life Sciences

We are very interested in accessing innovation and technology, but we can't hope to do everything ourselves. One way for us to do this is to set up the Innovation Village, to provide space for entrepreneurs and innovators in South Wales. [More]
Point of care measurement of hemoglobin: an interview with Katja Lemburg, EKF Diagnostics

Point of care measurement of hemoglobin: an interview with Katja Lemburg, EKF Diagnostics

Katja Lemburg discusses the next generation Hemo Control being launched in Europe at EuroMedLab, Paris 21-25th June. EKF will be exhibiting on Stand G005 (Level 1). [More]
Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

Using technology to protect diabetics from foot amputations: an interview with Heleen Kist, HCi Viocare

When people don’t receive the body’s natural signals due to neuropathy, they can unknowingly be exposing their feet to conditions that are known to cause foot ulcers, such as repeated pressure and shear... [More]
Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Scar management: an interview with Adele Atkinson, Associate Professor, School of Nursing

Scarring has been shown to have a significant impact on patients’ lives. As well as the physical burden associated with skin scarring, psychological strains can also negatively affect the quality of life for patients, with the majority (56%) considering themselves to be ‘abnormal’ due to their scars... [More]
Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Vaccines - a needle-free future? An interview with Thomas Johnston and Dr. Kees Leenhouts, Mucosis

Scientists recognize that 90% of pathogens actually enter the body through the mucosa and secondly, we have evolved a mucosal defense system that can be used to defend against disease... [More]
Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

To control reflux symptoms, many people take acid-controlling medications such as Proton Pump Inhibitors, or PPIs. The FDA, however, has issued warnings over the frequent or long-term continued use of PPIs... [More]
ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ICD-10 Clinical Modification: an interview with Dr. Jon Elion, Founder, ChartWise Medical Systems

ICD-10 is the tenth revision to the World Health Organization’s (WHO) International Classification of Diseases. ICD-10, like its predecessor, ICD-9, is based on a set of unique alphanumeric codes to identify known diseases and other health problems... [More]
Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Advances in thoracic surgery: an interview with Dan Wildman, VP Global Franchise Strategy & Innovation- Ethicon

Without a doubt, one of the most significant developments in thoracic surgery was the advent of video-assisted thoracoscopic surgery or VATS in the 1990s... [More]
Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

Countering Ebola misinformation: an interview with Dr Katie Geary, International SOS

People tried to avoid a healthcare situation and in doing so, they propagated it through the community because instead of being in isolation they remained around the family group and relied on usual cultural health remedies... [More]
Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

Warfarin and PT-INR testing: an interview with Paul Wright, CEO, Universal Biosensors

There are roughly 10 million people worldwide taking Warfarin, accounting for more than 200 million point of care (POC) PT-INR tests performed globally each year... [More]
Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Detecting bladder cancer from urine: an interview with Suzana Nahum-Zilberberg, CEO, BioLight

Bladder cancer is the seventh leading cancer affecting men worldwide and in the United States, it is the fourth leading cancer. Each year, about 350,000 cases are being detected worldwide, and the disease claims 165,000 lives every year. [More]
Advertisement
Advertisement